<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="helma.xsl"?>
<xmlroot xmlns:hop="http://www.helma.org/docs/guide/features/database">
  <hopobject id="2432" name="Page" prototype="Page" created="1363280116832" lastModified="1543337638691">
  <hop:parent idref="0" prototyperef="Root"/>
    <http_browser>Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.1; SV1)</http_browser>
    <lang>en-us</lang>
    <uri>bone-update</uri>
    <http_host>127.0.0.1:8080</http_host>
    <time type="date">27.11.2018 16:53:58 UTC</time>
    <pseudoparent idref="0" prototyperef="Root"/>
    <http_remotehost>127.0.0.1</http_remotehost>
    <hopsession>127.0.0.1t7f1ndaronga</hopsession>
    <user>default</user>
    <pvcount type="float">85.0</pvcount>
    <body>I don&apos;t like pubs &lt;a href=&quot;https://www.ssvoverath.de/stmap_c3db0.html?betagan.cialis.clarithromycin&quot;&gt;vinpocetine jarrow amazon&lt;/a&gt;  Two-way transparency is crucial to address this risk, &amp;ldquo;since it allows critical review of any secondary analysis by the public and the EMA&amp;rdquo;, they add. Moreover, there must be strong safeguards in place &amp;ldquo;to ensure that the clinical investments and intellectual property of innovators are not jeopardised by &amp;lsquo;free riders&amp;rsquo;&amp;rdquo;.
 </body>
    <http_language>en-US,en;q=0.8</http_language>
    <is_xhtml type="boolean">true</is_xhtml>
    <http_referer>http://beagleboard.org/bone-update/edit</http_referer>
  </hopobject>
</xmlroot>
